Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Lexicon Pharmaceuticals, Inc. (LXRX : NSDQ)
 
 • Company Description   
Lexicon Genetics Incorporated is a leader in defining the functions of genes for drug discovery using large-scale knockout mouse technology. Lexicon has invented high-throughput gene trapping technology to discover thousands of genes and expand its OmniBank library of tens of thousands of mouse clones. The Company uses an integrated platform of functional genomictechnologies to accelerate large-scale analysis of mammalian gene function for drug discovery.

Number of Employees: 87

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.77 Daily Weekly Monthly
20 Day Moving Average: 429,687 shares
Shares Outstanding: 149.59 (millions)
Market Capitalization: $264.78 (millions)
Beta: 1.53
52 Week High: $6.33
52 Week Low: $1.60
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -17.67% -7.29%
12 Week -38.97% -32.91%
Year To Date -55.08% -48.21%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2445 TECHNOLOGY FOREST BLVD. 11TH FLOOR
-
THE WOODLANDS,TX 77381
USA
ph: 281-863-3000
fax: 281-863-8010
klee@lexpharma.com http://www.lexpharma.com
 
 • General Corporate Information   
Officers
Lonnel Coats - Chief Executive Officer and President
Raymond Debbane - Chairman
Jeffrey L. Wade - President and Chief Financial Officer
Kristen L. Alexander - Vice President; Finance and Accounting
Philippe J. Amouyal - Director

Peer Information
Lexicon Pharmaceuticals, Inc. (CORR.)
Lexicon Pharmaceuticals, Inc. (RSPI)
Lexicon Pharmaceuticals, Inc. (CGXP)
Lexicon Pharmaceuticals, Inc. (BGEN)
Lexicon Pharmaceuticals, Inc. (GTBP)
Lexicon Pharmaceuticals, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 528872302
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 07/29/22
Share - Related Items
Shares Outstanding: 149.59
Most Recent Split Date: 5.00 (0.14:1)
Beta: 1.53
Market Capitalization: $264.78 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.14 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.05 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/29/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 35.40
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.86
Price/Cash Flow: -
Price / Sales: 859.68
EPS Growth
vs. Year Ago Period: -6.67%
vs. Previous Quarter: 5.88%
Sales Growth
vs. Year Ago Period: 37.04%
vs. Previous Quarter: 164.29%
ROE
03/31/22 - -75.21
12/31/21 - -65.01
09/30/21 - -47.29
ROA
03/31/22 - -58.52
12/31/21 - -52.07
09/30/21 - -37.19
Current Ratio
03/31/22 - 4.68
12/31/21 - 4.02
09/30/21 - 3.62
Quick Ratio
03/31/22 - -
12/31/21 - 4.02
09/30/21 - 3.62
Operating Margin
03/31/22 - -29,310.39
12/31/21 - -29,448.99
09/30/21 - -14,265.01
Net Margin
03/31/22 - -29,310.39
12/31/21 - -29,448.99
09/30/21 - -14,004.55
Pre-Tax Margin
03/31/22 - -29,310.39
12/31/21 - -29,448.99
09/30/21 - -14,004.55
Book Value
03/31/22 - 0.62
12/31/21 - 0.76
09/30/21 - 0.95
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.25
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 20.21
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©